78 results
Pulmonary Embolism Treatment
Systemic Thrombolysis
 - Exclude contraindications.
 - Indications:
   - Massive PE (definite indication)
submassive PE (risk ... 50mg IV) - 2% risk ... of ICH and 6% risk ... who are higher risk ... AcutePE #Management #CriticalCare
COVID-19: ICU Guidelines for the Non-Intensivist
Infection Control
Risk Factors for Severe Disease
Initial Laboratory Workup
COVID-19 Specific Medications
Respiratory
Cardiac
Hematologic
Neuro/Sedation

#COVID19 #ICU
COVID-19: ICU Guidelines ... Infection Control Risk ... Sedation #COVID19 #ICU ... #criticalcare #
Stress Ulcer Prophylaxis

Stress ulcerations are common in ICU patients and may lead to hemorrhage if not
are common in ICU ... ulceration or treatment ... Pathophysiology • Risk ... #Prophylaxis #criticalcare ... #pharmacology #
Pulmonary Embolism - Risk Stratification and Prognostication based on scores and clinical features

 • Bova score
Pulmonary Embolism ... - Risk Stratification ... @nickmmark #Pulmonary ... #Embolism #Risk ... stratification #criticalcare
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Chronic Obstructive Pulmonary ... chronic obstructive pulmonary ... and exacerbation risk ... of expiration; ICS ... #Pharmacology
Post-Intensive Care Syndrome (PICS)
Symptoms of PICS:
 - Physical Domain: Generalized weakness, Fatigue, Difficulty walking
 - Cognitive
Depression COMMON RISK ... FACTORS - ICU ... guide targeted treatments ... diagnosis #management #criticalcare ... #icu
COPD Exacerbations - Management
 • Identify Triggers
 • Assess Severity
 • Risk for Poor Outcomes
 •
Assess Severity • Risk ... Outcomes • Initial Treatment ... Exacerbation #Management #treatment ... #pulmonary
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
own benefits and risks ... the hypoglycemia risk ... #pharmacology #pharmacotherapy ... endocrinology #treatment
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... indicate preferred treatment ... long-acting β2-agonist; ICS ... #Management #Pulmonary ... GOLD2017 #LAMA #LABA #ICS
Azithromycin - since there has been a lot of noise around chloroquine/hydroxychloroquine, thought we can take
investigational treatments ... for potential DIs ... QT prolongation risk ... #Coronavirus #Treatment ... #Management #Pharmacology